Senior Tax Analyst at Illumina

Cambridge, England, United Kingdom

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years)Experience Level

Full TimeJob Type

UnknownVisa

Biotechnology, Genomics, HealthcareIndustries

Requirements

Direct tax experience in a high-growth environment, ideally with exposure to multinational operations
Qualified Chartered Accountant or Chartered Tax Adviser (or working towards it)
Strong grasp of current Corporation Tax laws and anti-tax avoidance legislation such as ATAD and DAC6
Exceptional analytical skills and accuracy, particularly in working with large datasets and spreadsheets
Proficient in SAP or similar ERP systems
Thrive in cross-functional collaboration with excellent communication skills
Comfortable navigating complex tax scenarios across jurisdictions
Experience with transfer pricing, R&D tax credits, and global structuring projects highly valued

Responsibilities

Prepare and complete Corporation Tax returns, both in-house and via outsourced providers
Compile UK-specific calculations including RDEC, patent box, and share-based payments
Manage CT prepayments to optimize cashflow and leverage discounts
Collaborate with the General Ledger team on local GAAP tax accounting and US GAAP conversions
Partner with local advisers to ensure correct tax treatment of global activities (e.g., FX, employee allowances, R&D)
Evaluate feasibility of bringing outsourced CT compliance in-house
Monitor PE risk and guide business expansion strategies
Support global supply chain and structuring projects
Ensure compliance with transfer pricing regulations, including local files and CbC reporting
Respond to tax audits, notices, and information requests
Work with internal systems and departments to ensure accurate documentation of tax positions
Assist with VAT and employment tax compliance as needed

Skills

Corporation Tax

ATAD

DAC6

SAP

Excel

Tax Compliance

Tax Planning

Financial Reporting

Illumina

Supports genomics startups through funding and resources

About Illumina

Illumina focuses on fostering innovation in the genomics industry by supporting startups through its Illumina Accelerator program. This program helps entrepreneurs create, launch, and grow genomics-focused companies by providing funding and resources. The accelerator operates in two main locations: the San Francisco Bay Area and Cambridge, UK. Illumina Accelerator has successfully invested in 68 genomics startups, which have collectively raised over $1 billion in venture capital. What sets Illumina apart from its competitors is its strong partnership with leading venture capital investors and its dedicated focus on the genomics sector. The goal of Illumina is to build a thriving ecosystem for genomics innovation, enabling new companies to emerge and advance the field.

San Diego, CaliforniaHeadquarters

1998Year Founded

$27.2MTotal Funding

IPOCompany Stage

Venture Capital, BiotechnologyIndustries

5,001-10,000Employees

Risks

Over-reliance on NVIDIA's AI technology may limit flexibility in AI solution adoption.

Standardizing proteomics data across platforms could challenge Illumina's data reliability.

Single-flow-cell NovaSeq X System might cannibalize sales of higher-end models.

Differentiation

Illumina leads in genomic sequencing with advanced AI integration and multiomic data analysis.

The company offers innovative array-based solutions for DNA, RNA, and protein analysis.

Illumina's global expansion includes a new Global Capability Center in Bengaluru.

Upsides

Collaboration with NVIDIA enhances drug discovery and clinical development through AI integration.

Pilot proteomics program with UK Biobank aims to generate crucial reference datasets.

Single-cell sequencing kits make high-throughput sequencing accessible to smaller labs.

Land your dream remote job 3x faster with AI

Try Jobo Free